Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Bioinformatics›Bayesian Gene Set Enrichment Analysis — Probabilistic Pathway Scoring
Process / pipelineBioinformatics / omics

Bayesian Gene Set Enrichment Analysis — Probabilistic Pathway Scoring

Bayesian Gene Set Enrichment Analysis · Also known as: Bayesian GSEA, BGSEA, Bayesian pathway scoring, probabilistic gene set testing

Bayesian gene set enrichment analysis (Bayesian GSEA) applies a probabilistic framework to determine whether predefined sets of genes — representing biological pathways, cellular processes, or functional categories — are collectively more differentially expressed than expected by chance. Unlike classical frequentist GSEA, the Bayesian approach models uncertainty in expression estimates explicitly, incorporates prior biological knowledge, and produces posterior probabilities of enrichment rather than raw p-values, enabling more principled inference especially in small-sample settings.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 2 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

Bayesian Gene Set Enrichment Analysis
Bayesian RNA-seq differe…Gene Set Enrichment Anal…Multi-omics gene set enr…Pathway Enrichment Analy…RNA-seq Differential Exp…Single-cell Gene Set Enr…Bayesian Metabolomics An…Machine learning-assiste…

When to use it

Use Bayesian GSEA when you have RNA-seq or microarray data and want to identify enriched biological pathways or gene sets while explicitly accounting for expression uncertainty — particularly in studies with small sample sizes (fewer than 10 per group) where frequentist methods lose power or produce unstable rankings. It is also appropriate when you wish to incorporate prior biological knowledge or when you need interpretable uncertainty estimates for clinical or regulatory reporting. Do NOT use it as a direct replacement for raw differential expression analysis — GSEA (Bayesian or otherwise) operates on gene-level statistics, not on raw counts, so DE analysis must precede it. Avoid Bayesian GSEA when the gene set database is very small or when the biological questions concern individual gene regulation rather than collective pathway behavior.

Strengths & limitations

Strengths
  • Explicit uncertainty quantification — posterior distributions communicate confidence in enrichment scores, not just point estimates.
  • Improved power in small-sample studies by borrowing strength across genes through the prior.
  • Natural shrinkage reduces spurious enrichment signals without arbitrary FDR cutoffs.
  • Flexible model specification allows incorporation of covariates, batch effects, and multi-condition designs.
  • Produces probabilistic outputs that align well with downstream decision-making in clinical or translational contexts.
Limitations
  • Computationally demanding — MCMC-based inference can be slow for genome-scale data with thousands of gene sets.
  • Prior specification requires domain expertise; poorly chosen priors can distort enrichment estimates.
  • Results depend on the gene set database used; enrichment claims are only as good as the curated annotations.
  • Less standardised than frequentist GSEA, making cross-study comparisons harder without shared modelling assumptions.

Frequently asked

How does Bayesian GSEA differ from standard (frequentist) GSEA?

Standard GSEA uses a permutation test to generate a null distribution and reports a nominal p-value and FDR q-value. Bayesian GSEA instead specifies a probabilistic model for gene expression, defines a prior over enrichment parameters, and outputs a posterior probability or credible interval for each gene set. The Bayesian version naturally quantifies uncertainty and can incorporate prior knowledge; the frequentist version is more widely implemented and easier to benchmark against established tools.

Do I need to run differential expression analysis before Bayesian GSEA?

In most implementations, yes. Bayesian GSEA typically operates on gene-level statistics (log fold-changes, t-statistics, or posterior effect sizes) that come from a prior DE step. Some methods integrate DE and enrichment into a single hierarchical model, but these are less common and more computationally intensive. Always clarify which input the chosen tool expects.

Which software packages implement Bayesian GSEA?

Implementations include the GSEABayes function in the limma R package, the BAYSEA tool, and custom MCMC pipelines in Stan or JAGS. The edgeR and DESeq2 ecosystems also provide empirical Bayes shrinkage that can feed into enrichment testing. No single dominant Bayesian GSEA tool exists, so the choice depends on the data type, sample size, and computational resources available.

How do I choose which gene set database to use?

The Molecular Signatures Database (MSigDB) is the most comprehensive and widely used source, offering hallmark gene sets, GO terms, pathway databases (KEGG, Reactome, WikiPathways), and others. Match the database to your biological question: hallmark sets for broad oncology questions, GO Biological Process for mechanistic depth, KEGG or Reactome for metabolic or signalling pathway specificity. Always use a version-controlled snapshot and report the database version in publications.

Is Bayesian GSEA suitable for single-cell RNA-seq data?

With adaptations, yes. Single-cell data introduce additional sparsity and cell-level heterogeneity that standard bulk-RNA Bayesian GSEA models do not capture well. Dedicated single-cell enrichment tools (e.g., AUCell, Vision, or scGSEA) are generally preferred for scRNA-seq, and some of these incorporate Bayesian or empirical-Bayes elements. Using a bulk-designed Bayesian GSEA method directly on single-cell data without modification is not recommended.

Sources

  1. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., ... & Mesirov, J. P. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences, 102(43), 15545-15550. DOI: 10.1073/pnas.0506580102 ↗
  2. Newton, M. A., Quintana, F. A., Den Boon, J. A., Bhattacharya, S., & Ahlquist, P. (2007). Random-set methods identify distinct aspects of the enrichment signal in gene-set analysis. The Annals of Applied Statistics, 1(1), 85-106. link ↗

How to cite this page

ScholarGate. (2026, June 3). Bayesian Gene Set Enrichment Analysis. ScholarGate. https://scholargate.app/en/bioinformatics/bayesian-gene-set-enrichment-analysis

Related methods

Bayesian RNA-seq differential expressionGene Set Enrichment AnalysisMulti-omics gene set enrichment analysisPathway Enrichment AnalysisRNA-seq Differential ExpressionSingle-cell Gene Set Enrichment Analysis

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • Bayesian RNA-seq differential expressionBioinformatics↔ compare
  • Gene Set Enrichment AnalysisBioinformatics↔ compare
  • Multi-omics gene set enrichment analysisBioinformatics↔ compare
  • Pathway Enrichment AnalysisBioinformatics↔ compare
  • RNA-seq Differential ExpressionBioinformatics↔ compare
  • Single-cell Gene Set Enrichment AnalysisBioinformatics↔ compare
Compare side by side →

Referenced by

Bayesian Metabolomics AnalysisMachine learning-assisted gene set enrichment analysis

Similar methods

Bayesian Pathway Enrichment AnalysisGene Set Enrichment AnalysisNetwork-based gene set enrichment analysisMachine learning-assisted gene set enrichment analysisPathway Enrichment AnalysisMulti-omics gene set enrichment analysisDifferential pathway enrichment analysisTime-series gene set enrichment analysis

Related reference concepts

Pathway Enrichment and Network AnalysisFunctional Genomics and Pathway AnalysisGene Ontology and Biological DatabasesGene Expression Signatures and Prognostic MarkersEmpirical Bayes MethodsFunctional Annotation of Genomic Variants

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — Bayesian Gene Set Enrichment Analysis (Bayesian Gene Set Enrichment Analysis). Retrieved 2026-07-21 from https://scholargate.app/en/bioinformatics/bayesian-gene-set-enrichment-analysis · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
Michael A. Newton, Frank A. Quintana and colleagues; building on Subramanian et al. GSEA framework
Year
2004–2007
Type
Probabilistic gene set enrichment method
DataType
Gene expression matrices (RNA-seq counts or microarray intensities) with curated gene set annotations (e.g., MSigDB, GO, KEGG)
Subfamily
Bioinformatics / omics
Related methods
Bayesian RNA-seq differential expressionGene Set Enrichment AnalysisMulti-omics gene set enrichment analysisPathway Enrichment AnalysisRNA-seq Differential ExpressionSingle-cell Gene Set Enrichment Analysis
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account